Evidence map›Paper›PMID 29684272›Full record

ArticleBiochemistry2018

The Mechanism of Acetyl Transfer Catalyzed by Mycobacterium tuberculosis GlmU.

Peter D Craggs, Stephane Mouilleron, Martin Rejzek, Cesira de Chiara, Robert J Young, Robert A Field, Argyrides Argyrou, Luiz Pedro S de Carvalho

Open access · hybridAbstract read
In one paragraph

Article in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Peter D CraggsPlatform Technology and Science , GlaxoSmithKline , Stevenage , U.K.
Stephane Mouilleron
Martin RejzekJohn Innes Centre , Norwich , U.K.
Cesira de Chiara
Robert J YoungPlatform Technology and Science , GlaxoSmithKline , Stevenage , U.K.ORCID 0000-0002-7763-0575
Robert A FieldJohn Innes Centre , Norwich , U.K.
Argyrides ArgyrouPlatform Technology and Science , GlaxoSmithKline , Stevenage , U.K.
Luiz Pedro S de CarvalhoORCID 0000-0003-2875-4552
GlaxoSmithKline (United Kingdom) · GBThe Francis Crick Institute · GBJohn Innes Centre · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J004561/1Biotechnology and Biological Sciences Research Council BBS/E/J/000C0618Biotechnology and Biological Sciences Research Council BBS/E/J/000PR9790Cancer Research UK FC001060Medical Research Council MC_U117533887Wellcome Trust FC001060
6 · The paper itself

Abstract

The biosynthetic pathway of peptidoglycan is essential for Mycobacterium tuberculosis. We report here the acetyltransferase substrate specificity and catalytic mechanism of the bifunctional N-acetyltransferase/uridylyltransferase from M. tuberculosis (GlmU). This enzyme is responsible for the final two steps of the synthesis of UDP- N-acetylglucosamine, which is an essential precursor of peptidoglycan, from glucosamine 1-phosphate, acetyl-coenzyme A, and uridine 5'-triphosphate. GlmU utilizes ternary complex formation to transfer an acetyl from acetyl-coenzyme A to glucosamine 1-phosphate to form N-acetylglucosamine 1-phosphate. Steady-state kinetic studies and equilibrium binding experiments indicate that GlmU follows a steady-state ordered kinetic mechanism, with acetyl-coenzyme A binding first, which triggers a conformational change in GlmU, followed by glucosamine 1-phosphate binding. Coenzyme A is the last product to dissociate. Chemistry is partially rate-limiting as indicated by pH-rate studies and solvent kinetic isotope effects. A novel crystal structure of a mimic of the Michaelis complex, with glucose 1-phosphate and acetyl-coenzyme A, helps us to propose the residues involved in deprotonation of glucosamine 1-phosphate and the loop movement that likely generates the active site required for glucosamine 1-phosphate to bind. Together, these results pave the way for the rational discovery of improved inhibitors against M. tuberculosis GlmU, some of which might become candidates for antibiotic discovery programs.

Indexed as

BiocatalysisBacterial ProteinsEnzyme InhibitorsHydrogen-Ion ConcentrationKineticsMagnesium ChlorideMolecular StructureMultienzyme ComplexesMycobacterium tuberculosisSubstrate SpecificityUridine Diphosphate N-AcetylglucosamineBacterial ProteinsEnzyme InhibitorsGlmU protein, Mycobacterium tuberculosisMagnesium ChlorideMultienzyme ComplexesUridine Diphosphate N-Acetylglucosamine

Identifiers

PMID29684272
PMCPMC6011181
OpenAlexW2799610005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.